Seminar | October 2 | 12-1 p.m. | 106 Stanley Hall
Joel Collier, Duke University
Joel Collier, Associate Professor of Biomedical Engineering, Duke University
"Active Immunotherapies from Supramolecular Assemblies"
Active immunotherapies, which elicit protective or therapeutic immune responses against chosen antigens, have been among the most successful medical technologies ever developed. Nevertheless, a tremendous range of potential therapeutic targets remain without effective immunotherapies, and these span numerous infectious diseases, cancers, and autologous targets requiring neutralization or clearance. This talk will discuss supramolecular peptide materials designed to systematically discover and elicit protective or therapeutic immune responses, particularly towards HIV, influenza, and inflammatory cytokines.